| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALNYLAM PHARMACEUTICALS INC | 1,092,516 | 55,991,000 | 14.74% | ||
| 2 | AVEXIS INC COM | 623,330 | 47,392,000 | 12.47% | ||
| 3 | BRISTOL MYERS SQUIBB CO | 570,692 | 31,034,000 | 8.17% | ||
| 4 | LA JOLLA PHARMACEUTICAL CO | 1,028,929 | 30,714,000 | 8.08% | ||
| 5 | BIOCRYST PHARMACEUTICALS | 3,458,120 | 29,048,000 | 7.65% | ||
| 6 | MEDICINES CO | 572,689 | 28,004,000 | 7.37% | ||
| 7 | REGENXBIO INC COM | 1,216,505 | 23,479,000 | 6.18% | ||
| 8 | Atara Biotherapeutics Inc | 908,733 | 18,674,000 | 4.92% | ||
| 9 | AGENUS INC | 4,245,882 | 16,007,000 | 4.21% | ||
| 10 | PTC THERAPEUTICS INC | 1,305,643 | 12,848,000 | 3.38% | ||
| 11 | INCYTE CORP | 82,490 | 11,026,000 | 2.90% | ||
| 12 | Oxford Immunotec Global PLC | 612,903 | 9,494,000 | 2.50% | ||
| 13 | BLUEBIRD BIO INC COM | 103,617 | 9,419,000 | 2.48% | ||
| 14 | MASIMO CORP | 80,900 | 7,545,000 | 1.99% | ||
| 15 | ORASURE TECHNOLOGIES INC | 566,230 | 7,321,000 | 1.93% | ||
| 16 | VIVEVE MED INC COM NEW | 1,145,736 | 7,253,000 | 1.91% | ||
| 17 | DICERNA PHARMACEUTICALS INC | 2,062,991 | 7,014,000 | 1.85% | ||
| 18 | CORIUM INTERNATIONAL INC | 1,448,991 | 6,057,000 | 1.59% | ||
| 19 | TACTILE SYS TECHNOLOGY INC | 287,876 | 5,455,000 | 1.44% | ||
| 20 | ARBUTUS BIOPHARMA CORP | 1,446,587 | 4,701,000 | 1.24% | ||
| 21 | VIEWRAY INC COM USD0.01 | 515,612 | 4,388,000 | 1.16% | ||
| 22 | INVUITY INC | 470,167 | 3,738,000 | 0.98% | ||
| 23 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 26,183 | 965,000 | 0.25% | ||
| 24 | CELLDEX THERAPEUTICS INC NEW | 241,699 | 873,000 | 0.23% | ||
| 25 | BioPharmX Corporation | 1,283,951 | 648,000 | 0.17% | ||
| 26 | SENSUS HEATLHCARE INC | 90,404 | 397,000 | 0.10% | ||
| 27 | Natera, Inc. | 31,693 | 281,000 | 0.07% | ||
| 28 | Sensus Healthcare, Inc @6.75 6 | 155,000 | 136,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-17-005309, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
